FATE - FATE THERAPEUTICS INC
IEX Last Trade
1.615
-0.005 -0.310%
Share volume: 26,034
Last Updated: Thu 26 Dec 2024 08:30:04 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$1.62
-0.01
-0.31%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-03 | 2022-11-03 | 2023-02-28 | 2023-05-03 | 2023-08-08 | 2023-11-08 | 2024-02-26 | 2024-05-09 | |
| Total revenue | 18.549 M | 14.981 M | 44.356 M | 58.980 M | 933.000 K | 1.944 M | 1.676 M | 1.925 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 18.549 M | 14.981 M | 44.356 M | 58.980 M | 933.000 K | 1.944 M | 1.676 M | 1.925 M | |
| -19.24% | 196.08% | 32.97% | -98.42% | 108.36% | -13.79% | 14.86% | |||
| Operating expenses | 101.658 M | 101.372 M | 108.775 M | 87.572 M | 63.498 M | 53.223 M | 49.751 M | 52.993 M | |
| Selling general and admin | 20.351 M | 21.555 M | 21.584 M | 21.943 M | 22.622 M | 18.948 M | 17.935 M | 20.855 M | |
| Research and development | 81.307 M | 79.817 M | 87.191 M | 65.629 M | 40.876 M | 34.275 M | 31.816 M | 32.138 M | |
| Total expenses | 101.658 M | 101.372 M | 108.775 M | 87.572 M | 63.498 M | 53.223 M | 49.751 M | 52.993 M | |
| -0.28% | 7.30% | -19.49% | -27.49% | -16.18% | -6.52% | 6.52% | |||
| Operating income | -83.109 M | -86.391 M | -64.419 M | -28.592 M | -62.565 M | -51.279 M | -48.075 M | -51.068 M | |
| Ebit | -83.109 M | -86.391 M | -64.419 M | -28.592 M | -62.565 M | -51.279 M | -48.075 M | -51.068 M | |
| Pretax income | -76.105 M | -83.563 M | -56.363 M | -18.881 M | -52.755 M | -45.170 M | -44.122 M | -48.004 M | |
| 9.80% | -32.55% | -66.50% | 179.41% | -14.38% | -2.32% | 8.80% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -76.105 M | -83.563 M | -56.363 M | -18.881 M | -52.755 M | -45.170 M | -44.122 M | -48.004 M | |
| -9.80% | 32.55% | 66.50% | -179.41% | 14.38% | 2.32% | -8.80% | |||
| Net income | -76.105 M | -83.563 M | -56.363 M | -18.881 M | -52.755 M | -45.170 M | -44.122 M | -48.004 M | |
| -9.80% | 32.55% | 66.50% | -179.41% | 14.38% | 2.32% | -8.80% |